Clinical Trials Logo

Recurrent Skin Cancer clinical trials

View clinical trials related to Recurrent Skin Cancer.

Filter by:

NCT ID: NCT02507076 Withdrawn - Recurrent Melanoma Clinical Trials

Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma

Start date: April 2012
Phase: N/A
Study type: Interventional

This pilot clinical trial studies isolated limb perfusion with melphalan in treating patients with stage IIIB-IV melanoma or sarcoma. Drugs used in chemotherapy, such as melphalan, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Heating a chemotherapy solution and infusing it directly into the arteries around the tumor may kill more tumor cells.

NCT ID: NCT02324608 Recruiting - Clinical trials for Recurrent Skin Cancer

Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer

Start date: January 2015
Phase: N/A
Study type: Interventional

This pilot clinical trial studies the side effects and how well cetuximab before surgery works in treating patients with skin cancer that forms, grows, and spreads quickly and has spread from where it started to nearby tissue or lymph nodes. Monoclonal antibodies, such as cetuximab, may block tumor growth in different ways be targeting certain cells. Giving cetuximab before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed.

NCT ID: NCT02303041 Active, not recruiting - Clinical trials for Recurrent Skin Cancer

Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma

Start date: February 2015
Phase: N/A
Study type: Interventional

This pilot trial studies how well sonidegib and buparlisib work in treating patients with basal cell carcinoma that has spread to other places in the body. Sonidegib and buparlisib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

NCT ID: NCT01823679 Terminated - Clinical trials for Recurrent Skin Cancer

Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin

Start date: March 2013
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well capecitabine works in treating patients with advanced or recurrent squamous cell carcinoma of the skin. Drugs used in chemotherapy, such as capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.

NCT ID: NCT01791894 Completed - Clinical trials for Recurrent Skin Cancer

Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma

Start date: April 2013
Phase: N/A
Study type: Interventional

This pilot clinical trial studies arsenic trioxide in treating patients with basal cell carcinoma. Drugs used in chemotherapy, such as arsenic trioxide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stop them from dividing

NCT ID: NCT01631331 Active, not recruiting - Clinical trials for Recurrent Skin Cancer

Vismodegib in Treating Patients With Basal Cell Carcinoma

Start date: June 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to learn about the effect of vismodegib on sporadic basal cell carcinoma (BCCs) prior to surgical removal.

NCT ID: NCT01465815 Withdrawn - Clinical trials for Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity

Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN)

Start date: December 2011
Phase: Phase 1/Phase 2
Study type: Interventional

This phase I/II trial studies the side effects and best dose of linsitinib when given together with erlotinib hydrochloride and radiation therapy after surgery in treating patients with advanced or recurrent head and neck cancer. Erlotinib hydrochloride and linsitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving radiation therapy together with erlotinib hydrochloride and linsitinib may kill more tumor cells. Giving these treatments after surgery may kill any tumor cells that remain after surgery.

NCT ID: NCT01292668 Completed - Pain Clinical Trials

Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer

Start date: March 2011
Phase: Phase 1
Study type: Interventional

RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, cancer cells are killed. Photodynamic therapy using methyl-5-aminolevulinate hydrochloride cream may be effective against skin cancer. PURPOSE: This phase I trial is studying the side effects and best dose of photodynamic therapy with methyl-5-aminolevulinate hydrochloride cream in determining pain threshold patients with skin cancer

NCT ID: NCT00563290 Completed - Clinical trials for Stage I Chronic Lymphocytic Leukemia

Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia

Start date: November 2007
Phase: Phase 2
Study type: Interventional

This phase II trial is studying how well dasatinib works in treating patients with unresectable or metastatic squamous cell skin cancer or RAI Stage 0-I chronic lymphocytic leukemia. Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

NCT ID: NCT00126555 Completed - Clinical trials for Recurrent Skin Cancer

Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer

Start date: March 2005
Phase: Phase 2
Study type: Interventional

The goal of this clinical research study is to learn if giving Iressa (Gefitinib or ZD1839) with surgery and/or radiation will help to control squamous cell carcinoma of the skin. The safety of this treatment will also be studied